In a meta-analysis of prospective studies that examined the performance of CSF biomarkers in predicting the conversion from mild cognitive impairment to Alzheimer’s disease, the Aβ42/p-tau ratio exhibited a high predictive value, particularly in patients younger than 70 years [21]. This evidence concerns the gene MAPT and Alzheimer disease.